Ubiquitous Assessment of the Recovery of Cancer Patients Using Consumer-Level Activity Trackers

Performance Status (PS) variability is a powerful tool to evaluate overall condition, treatment needs and survival chances of cancer patients. Traditionally, its assessment has relied on the experience of oncologists when interpreting results of clinical tests and when interviewing the patients. Meanwhile, consumer-level activity trackers have obtained good results in behavior-change oriented intervention trials and Fitbit devices have demonstrated enough reliability to provide objective data related to physical activity, but the clinical possibilities of the data collected has been neglected. This work presents a system design for ubiquitous assessment of PS by means of objective and quantifiable data from different sources: medical history, self-reported quality-of-life questionnaires and a commercial activity tracker Fitbit Alta HR. The system proposed aims to contextualize and model the recovery process of breast cancer patients during chemotherapy treatment.

[1]  Gregory M Dominick,et al.  Physical Activity Assessment Between Consumer- and Research-Grade Accelerometers: A Comparative Study in Free-Living Conditions , 2016, JMIR mHealth and uHealth.

[2]  L. Neubeck,et al.  Validation of Fitbit-Flex as a measure of free-living physical activity in a community-based phase III cardiac rehabilitation population , 2016, European journal of preventive cardiology.

[3]  Héctor Pomares,et al.  First Approach to Automatic Performance Status Evaluation and Physical Activity Recognition in Cancer Patients , 2016, 2016 15th International Conference on Ubiquitous Computing and Communications and 2016 International Symposium on Cyberspace and Security (IUCC-CSS).

[4]  T. Parker,et al.  Congruent Accuracy of Wrist-worn Activity Trackers during Controlled and Free-living Conditions , 2018 .

[5]  Gregory M Dominick,et al.  Modeling Clinically Validated Physical Activity Assessments Using Commodity Hardware , 2018, IEEE Journal of Biomedical and Health Informatics.

[6]  Sheri J. Hartman,et al.  Patterns of Fitbit Use and Activity Levels Throughout a Physical Activity Intervention: Exploratory Analysis from a Randomized Controlled Trial , 2018, JMIR mHealth and uHealth.

[7]  Andrea M. Comptour,et al.  Validity and reliability of Fitbit activity monitors compared to ActiGraph GT3X+ with female adults in a free-living environment. , 2017, Journal of science and medicine in sport.

[8]  C. Anders,et al.  Measuring and understanding adherence in a home-based exercise intervention during chemotherapy for early breast cancer , 2018, Breast Cancer Research and Treatment.

[9]  Emil Frei,et al.  Appraisal of methods for the study of chemotherapy of cancer in man: Comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide , 1960 .

[10]  Clayon B Hamilton,et al.  Accuracy of Fitbit Devices: Systematic Review and Narrative Syntheses of Quantitative Data , 2018, JMIR mHealth and uHealth.

[11]  Gregory J Welk,et al.  Comparison of Consumer and Research Monitors under Semistructured Settings. , 2016, Medicine and science in sports and exercise.

[12]  Merrill D. Funk,et al.  Validity of wrist-worn consumer products to measure heart rate and energy expenditure , 2018, Digital health.

[13]  Steven Piantadosi,et al.  Wearable activity monitors in oncology trials: Current use of an emerging technology. , 2018, Contemporary clinical trials.

[14]  D. Karnofsky The clinical evaluation of chemotherapeutic agents in cancer , 1949 .

[15]  J. Schwartz,et al.  Abstract MP11: Fitbit: An Accurate and Reliable Device for Wireless Physical Activity Tracking , 2015 .

[16]  Arjun Gupta,et al.  Promise of Wearable Physical Activity Monitors in Oncology Practice. , 2017, Journal of oncology practice.

[17]  J. Yates,et al.  Evaluation of patients with advanced cancer using the karnofsky performance status , 1980, Cancer.

[18]  Armin Shahrokni,et al.  Moving beyond Karnofsky and ECOG Performance Status Assessments with New Technologies , 2016, Journal of oncology.

[19]  Stacey A. Kenfield,et al.  The Fitbit One Physical Activity Tracker in Men With Prostate Cancer: Validation Study , 2017, JMIR cancer.

[20]  Max Dahele,et al.  Physical activity monitoring: a responsive and meaningful patient-centered outcome for surgery, chemotherapy, or radiotherapy? , 2012, Journal of pain and symptom management.

[21]  Corby K. Martin,et al.  Effectiveness of SmartMoms, a Novel eHealth Intervention for Management of Gestational Weight Gain: Randomized Controlled Pilot Trial , 2017, JMIR mHealth and uHealth.

[22]  S. Braun,et al.  Counting Steps in Activities of Daily Living in People With a Chronic Disease Using Nine Commercially Available Fitness Trackers: Cross-Sectional Validity Study , 2018, JMIR mHealth and uHealth.

[23]  Gianluca De Leo,et al.  Healthy lifestyle intervention for adult clinic patients with type 2 diabetes mellitus. , 2017, Diabetes management.

[24]  C. Tudor-Locke,et al.  How Many Steps/Day Are Enough? , 2004, Sports medicine.